Aspen Pharmacare. Down 37% From 3rd & Final Sell Call

The final call was on the peak of 29 September. Looking back, good call (hope it helped!).

Down 37% From 3rd & Final Sell Call.

Updates 1 to 3 attached.
Chart PatternsTechnical IndicatorsTrend Analysis

関連の投稿

免責事項